Pazopanib in the treatment of advanced renal cell carcinoma
about
Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial.Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma modelPhotoactivatable Caged Prodrugs of VEGFR-2 Kinase Inhibitors.Novel investigational therapies for treating biliary tract carcinoma.Current and emerging EGFR therapies for glioblastoma.Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
P2860
Pazopanib in the treatment of advanced renal cell carcinoma
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Pazopanib in the treatment of advanced renal cell carcinoma
@ast
Pazopanib in the treatment of advanced renal cell carcinoma
@en
Pazopanib in the treatment of advanced renal cell carcinoma
@nl
type
label
Pazopanib in the treatment of advanced renal cell carcinoma
@ast
Pazopanib in the treatment of advanced renal cell carcinoma
@en
Pazopanib in the treatment of advanced renal cell carcinoma
@nl
prefLabel
Pazopanib in the treatment of advanced renal cell carcinoma
@ast
Pazopanib in the treatment of advanced renal cell carcinoma
@en
Pazopanib in the treatment of advanced renal cell carcinoma
@nl
P2860
P356
P1476
Pazopanib in the treatment of advanced renal cell carcinoma
@en
P2093
David Cella
P2860
P356
10.1177/1756287215614236
P407
P577
2016-02-01T00:00:00Z